Lifeway Foods, Inc. (LWAY)
After hours:
| Previous Close | 27.31 |
| Open | 27.90 |
| Bid | 26.74 x 300 |
| Ask | 26.94 x 200 |
| Day's Range | 26.18 - 28.61 |
| 52 Week Range | 5.75 - 28.61 |
| Volume | |
| Avg. Volume | 136,990 |
| Market Cap | 401.504M |
| Beta (5Y Monthly) | 1.30 |
| PE Ratio (TTM) | 36.35 |
| EPS (TTM) | 0.74 |
| Earnings Date | May 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 29, 2013 |
| 1y Target Est | 20.50 |
ZacksLifeway Foods (LWAY) Stock Sinks As Market Gains: What You Should Know
In the most recent trading session, Lifeway Foods (LWAY) closed at $26.90, indicating a -1.5% shift from the previous trading day.
ZacksLifeway Foods (LWAY) Readies for Q1 Earnings: What to Expect?
Lifeway Foods' (LWAY) Q1 results are likely to reflect gains from product innovation and customer engagement, while challenges associated with a volatile operational landscape persist.
PR NewswireLifeway Foods® Applauds New Research Examining the Impact of Probiotics in Dairy Kefir on the Microbiome in Children with ADHD
Lifeway Foods, Inc. (Nasdaq: LWAY), a leading U.S. supplier of kefir and fermented probiotic products that support the microbiome, applauds the recent study protocol titled, "Randomised controlled trial of the effects of kefir on behaviour, sleep and the microbiome in children with ADHD: a study protocol," published by the British Medical Journal (BMJ) Open Journal. The trial will test diet-based intervention targeting gut health to support the wellbeing of children with ADHD, as previous resear
